QUALITY ASSURANCE & GMP REGULATORY SUPPORT

QUALITY ASSURANCE & GMP REGULATORY SUPPORT “Strengthen Your Quality System. Be Audit-Ready. Stay GMP Compliant” AASP Lifesciences Pvt. Ltd. offers professional part-time Quality Assurance and GMP regulatory support to pharmaceutical and healthcare manufacturing organizations seeking experienced QA assistance without the need for a full-time resource. πŸ”Ή OUR QA & GMP SUPPORT SERVICES βœ… GMP Audit … Read more

CAPA Effectiveness in the Pharma Industry

CAPA Effectiveness in the Pharma Industry Repeated Environmental Monitoring Excursions Scenario: During routine environmental monitoring of a Grade C manufacturing area, repeated excursions in microbial counts are observed at a specific monitoring location. Initial Observation –Β Over three months: Multiple microbial excursions occurred at the same location. Initial investigations focused primarily on cleaning and operator practices. … Read more

Pharmaceutical Change HVAC and Environmental Control

Pharmaceutical Change Control: GMP Process, Risk Assessment & Implementation Pharmaceutical Change: HVAC and Environmental Control 1. Proposed Pharmaceutical Change: Replace and upgrade an existing HVAC system serving a Grade C manufacturing area to improve temperature, relative humidity, pressure differential, air-change performance, and overall environmental control. Reason for This Pharmaceutical Change: The existing HVAC system is … Read more

Quality by Design (QbD)

Quality by Design (QbD) Framework for tablet manufacturing, covering Critical Quality Attributes (CQAs), Critical Process Parameters (CPPs), their relationship, and a practical risk assessment. 1. Tablet Manufacturing – Critical Quality Attributes (CQAs) CQAs are physical, chemical, microbiological, or performance characteristics that must remain within an appropriate limit/range to ensure the finished tablet meets its intended … Read more

Pharmaceutical Quality Risk Management: FDA & ICH Q9 Guide

Quality Risk Management for New Products, Processes, Equipment, Facilities, Technology Transfer and Scale-Up   Introducing a new pharmaceutical product, manufacturing process, equipment, facility modification, technology transfer, scale-up activity, or process change can create significant quality risks.Β A change that appears technically simple may affect: Critical Quality Attributes (CQAs) Critical Process Parameters (CPPs) Material attributes Process capability … Read more

Pharmaceutical eQMS Digitalization FDA Compliance

Pharmaceutical eQMS & Digitalization FDA Compliance: A Practical Guide for FDA-Regulated Companies Digital transformation is changing how pharmaceutical companies manage quality, compliance, documentation, and operational risk. For many years, pharmaceutical Quality Assurance departments relied heavily on paper-based systems, spreadsheets, email approvals, and manually maintained quality records. While these approaches can support basic operations, they can … Read more

Continual Improvement of the Pharmaceutical Quality System: A Practical FDA, ICH & PIC/S Framework

Continual Improvement of the Pharmaceutical Quality System: A Practical FDA, ICH & PIC/S Framework A pharmaceutical quality system should do more than demonstrate compliance. It should enable an organization to identify emerging risks, understand process performance, learn from quality events, and continuously improve its operations. For pharmaceutical manufacturers supplying the United States, continual improvement should … Read more

Key Quality Systems in the Pharmaceutical IndustryΒ 

Key Quality Systems in the Pharmaceutical IndustryΒ  A Pharmaceutical Quality Management System (PQMS) is a comprehensive framework designed to ensure that pharmaceutical products are consistently manufactured, tested, stored, and distributed to meet predefined quality, safety, efficacy, and regulatory requirements. It is based on the principles of ICH Q10 Pharmaceutical Quality System, WHO GMP, EU GMP, … Read more

SOP for Procedure for Assigning New Product Retest Date

SOP for Procedure for Assigning New Product Retest Date 1.0 Objective To establish a procedure for assigning or extending the retest date of products based on stability data, ensuring product quality, safety, and compliance with regulatory requirements. 2.0 Scope This SOP is applicable to all finished products manufactured for which retest date assignment or extension … Read more

SOP forΒ Loan License Product Manufacturing

SOP forΒ Loan License Product Manufacturing 1. Purpose To define the procedure for manufacturing, control, and release of products under a loan license arrangement, ensuring compliance with applicable GMP guidelines and regulatory requirements. 2. Scope This SOP applies to all products manufactured at the site under a loan license agreement for third-party (contract giver) companies. 3. … Read more